Could assist in managing age-related weight gain and metabolic decline
These concerns were initially based on biological evidence indicating that the incretin system and the GLP-1-receptor might play a role in the development of cholangiocarcinoma [5,6,7], and further highlighted by an observational study using data from the UK Clinical Practice Research Datalink [8] showing that use of DPP4 inhibitors, compared with other second- or third-line glucose-lowering drugs, was associated with an increased risk of cholangiocarcinoma (HR 1.77 [95% CI 1.04, 3.01])
Pharmacy-grade sourcing: both Tesamorelin and Ipamorelin are dispensed through a licensed compounding pharmacy
Metabolites 2023;14(1):12
It plays an indirect role in the prevention of oxidative damage in cells by maintaining intracellular reduced glutathione (GSH)
Undershooting is fine: only 57.4% of the REDEFINE 1 combination arm was on the full dose at week 68, averaging 20.4%